Bleomycin (Hospira, Inc.)
Welcome to the PulseAid listing for the Bleomycin drug offered from Hospira, Inc.. This Cytoprotective Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Hospira, Inc. |
| NON-PROPRIETARY NAME: | BLEOMYCIN |
| SUBSTANCE NAME: | BLEOMYCIN SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cytoprotective Agent [EPC] |
| ROUTE: | INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2000-04-10 |
| END MARKETING DATE: | 0000-00-00 |
Bleomycin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Bleomycin from Hospira, Inc. |
| LABELER NAME: | Hospira, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 30([USP’U]/1) |
| START MARKETING DATE: | 2000-04-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 61703-323_f7e4a09f-d094-45e3-8daa-e4675c35294f |
| PRODUCT NDC: | 61703-323 |
| APPLICATION NUMBER: | ANDA065031 |
Other BLEOMYCIN SULFATE Pharmaceutical Manufacturers / Labelers:
